Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling. [electronic resource]
Producer: 20160106Description: 70 p. digitalISSN:- 1471-2407
- Alternative Splicing
- Animals
- Antineoplastic Agents -- administration & dosage
- Biomarkers
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Transformation, Neoplastic -- genetics
- Cluster Analysis
- Dermcidins -- genetics
- Disease Models, Animal
- Female
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Heterografts
- Humans
- Immunohistochemistry
- Receptor, ErbB-2 -- antagonists & inhibitors
- Signal Transduction
- Trastuzumab -- administration & dosage
- Tumor Burden -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.